NCT04312841 2025-02-28
Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
Ohio State University Comprehensive Cancer Center
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center